Editor’s Letter

27 0

Welcome to the 9th edition of HD Insights. We are grateful to the Huntington Study Group (HSG), our sponsors, and our over 2,500 subscribers for their continuing support of our mission.

In this special edition, we feature Dr. Ira Shoulson, founder and leader of the HSG from 1996 to 2014. Dr. Shoulson’s leadership and vision have been powerful forces for HD research for forty years. HD Insights also brings you the nominees and winners of the first Insights of the Year competition. The HD Insights staff and expert HD researchers nominated eleven papers published between July 2013 and July 2014 in HD basic science, clinical research, and biomarkers research, for consideration by our Editorial Board. The Board voted on the papers to select the most influential paper in each category. As a result, Drs. Francesca Cicchetti, Chris S. Tang, and X. William Yang will be presenting their winning research in a special panel session at the HSG meeting. In addition to these highlights, we bring you an interview with Ms. Julie Smith, President and CEO (designate) of Raptor Pharmaceuticals, who tells of her hopes for the company’s ongoing clinical trial with cysteamine bitartrate in HD. Our interview with Ms. Smith was edited by our newest team member, Associate Editor Ryan Korn, whose contributions we will feature in the coming year.

HD Insights relies on the support of firms dedicated to developing novel treatments to bring the latest research to the international HD research community. If you are interested in becoming a supporter, please contact me at editor@hdinsights.org. We welcome new contributors, suggestions for topics, and ideas about how we can better serve you. If you or someone you know would like to share their ideas with over 2,500 HD researchers and clinicians around the world, please contact me at editor@hdinsights.org. Finally, subscription to HD Insights is always free: simply send us an email at subscribe@hdinsights.org

Dorsey_feat

 

 

 

 

 

 

 

 

Ray Dorsey, MD

Editor, HD INSIGHTSTM

HD DISCLOSURES: DR. DORSEY RECEIVES GRANT SUPPORT FROM PRANA BIOTECHNOLOGY AND AUSPEX PHARMACEUTICALS


Editorial Board Members

Ray Dorsey, MD — Editor, University of Rochester

Donald Kennedy, PhD — Stanford University

Nobuyuki Nukina, MD, PhD — Riken Brain Science Institute

Rodrigo Osorio — Agrupación Chilena de Huntington

Bernard Ravina, MD — Voyager Therapeutics

Ralf Reilmann, MD, PhD — George Huntington Institute

Sarah Tabrizi, MBChB, PhD — University College London

Leslie Thompson, PhD — University of California Irvine

Huntington Study Group

Shari Kinel, JD — HSG Executive Director

Liz McCarthy, BA — HSG Administrative Manager

Contributors

Meredith A. Achey, BM

Francesca Cicchetti, PhD

Laura E. Clemens

Christina Colletta, BA

Nellie Georgiou-Karistianis, PhD

Flaviano Giogini, PhD

Victoria Gonzalez, MD, PhD

Steven M. Hersch, MD, PhD

Erik K. H. Jansson

Robert Mason, PhD

Miriam Moscovitch-Lopatin, PhD, PMP

Lise Munsie, PhD

Diana Rosas, MD Chris C. Tang, MD, PhD

William Yang, MD, PhD

Publication Staff

Meredith A. Achey, BM — Deputy Editor

Ryan Korn, BA — Associate Editor

Robin Taylor — Production Editor

Martin Holmes — Technical Editor

David Kolko — Distribution Specialist

Related Post

MEET THE COMPOUND: AMT-130

February 22, 2017 0
By: Meredith A. Achey, BM MANUFACTURER: uniQure COMPOUND: Artificial micro RNA targeting human huntingtin, carried by an adeno-associated virus 5…

Highlights of CHDI

May 30, 2017 0
The 12th Annual CHDI HD Therapeutics Conference was held in St. Julian’s, Malta, April 24–27, 2017. By: Nicholas Caron, PhD…

Research Round-Up

September 1, 2013 0
By: Lise Munsie, PhD In the lab. . . Cepeda and colleagues performed an electrophysiological study of the striatal microcircuit…

Meet the Next Generation

October 17, 2015 0
As the 25th anniversary of the identification of the genetic expansion responsible for HD approaches, a new generation of HD…